Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
Evaluate effect on cells and patient response to study medications, assess side effects of
these medications, and evaluate chemicals in cells that may tell how the drug works, before,
and after receiving the study medications.